Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours

被引:70
作者
Yao, Y [1 ]
Kubota, T [1 ]
Sato, K [1 ]
Kitai, R [1 ]
Takeuchi, H [1 ]
Arishima, H [1 ]
机构
[1] Fukui Med Univ, Dept Neurosurg, Fukui, Japan
关键词
vascular endothelial growth factor; vascular endothelial growth factor receptors; prognosis; astrocytic tumours;
D O I
10.1007/s007010170122
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background. Vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) is an important regulator of angiogenesis and vascular permeability. Method. We examined immunohistochemically expressions of VEGF and its corresponding receptors Flt-1 and Flk-1 in a series of 50 astrocytic tumours, and correlated their expressions with the degree of angiogenesis, brain edema and prognosis. Findings. There were significant relationships between VEGF, Flk-1 expressions and glioma malignancy grading, intratumoural vascularity and peritumoural brain edema, respectively. Patients with VEGF positive low grade astrocytoma and glioblastoma multiforme had a significantly shorter mean overall survival time than those with negative tumours (P = 0.0010 and 0.0180, respectively). Flk-1 is also a significant prognostic factor within each tumour grade, which has a negative impact on overall survival. Additionally, overexpression of VEGF and Flk-1 were significantly associated with earlier recurrence in patients with low grade astrocytomas (P = 0.0018 and 0.0240, respectively). Interpretation. It is possible to subcategorize each grade of astrocytic tumours based on their VEGF and Flk-1 staining pattern, which may be crucial in predicting the biological behavior of tumours and thus provide useful information with regard to adequate treatment.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 45 条
[21]  
2-A
[22]   HIGH-AFFINITY VEGF BINDING AND DEVELOPMENTAL EXPRESSION SUGGEST FLK-1 AS A MAJOR REGULATOR OF VASCULOGENESIS AND ANGIOGENESIS [J].
MILLAUER, B ;
WIZIGMANNVOOS, S ;
SCHNURCH, H ;
MARTINEZ, R ;
MOLLER, NPH ;
RISAU, W ;
ULLRICH, A .
CELL, 1993, 72 (06) :835-846
[23]   GLIOBLASTOMA GROWTH INHIBITED IN-VIVO BY A DOMINANT-NEGATIVE FLK-1 MUTANT [J].
MILLAUER, B ;
SHAWVER, LK ;
PLATE, KH ;
RISAU, W ;
ULLRICH, A .
NATURE, 1994, 367 (6463) :576-579
[24]   Vascular endothelial growth factor (VEGF) in astrocytic gliomas - a prognostic factor? [J].
Oehring, RD ;
Miletic, M ;
Valter, MM ;
Pietsch, T ;
Neumann, J ;
Fimmers, R ;
Schlegel, U .
JOURNAL OF NEURO-ONCOLOGY, 1999, 45 (02) :117-125
[25]   Endostatin: An endogenous inhibitor of angiogenesis and tumor growth [J].
OReilly, MS ;
Boehm, T ;
Shing, Y ;
Fukai, N ;
Vasios, G ;
Lane, WS ;
Flynn, E ;
Birkhead, JR ;
Olsen, BR ;
Folkman, J .
CELL, 1997, 88 (02) :277-285
[26]   Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas [J].
Piepmeier, J ;
Christopher, S ;
Spencer, D ;
Byrne, T ;
Kim, J ;
Knisel, JP ;
Lacy, J ;
Tsukerman, L ;
Makuch, R .
NEUROSURGERY, 1996, 38 (05) :872-878
[27]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IS A POTENTIAL TUMOR ANGIOGENESIS FACTOR IN HUMAN GLIOMAS INVIVO [J].
PLATE, KH ;
BREIER, G ;
WEICH, HA ;
RISAU, W .
NATURE, 1992, 359 (6398) :845-848
[28]   VASCULAR ENDOTHELIAL GROWTH-FACTOR AND GLIOMA ANGIOGENESIS - COORDINATE INDUCTION OF VEGF RECEPTORS, DISTRIBUTION OF VEGF PROTEIN AND POSSIBLE IN-VIVO REGULATORY MECHANISMS [J].
PLATE, KH ;
BREIER, G ;
WEICH, HA ;
MENNEL, HD ;
RISAU, W .
INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (04) :520-529
[29]  
Ravi R, 2000, GENE DEV, V14, P34
[30]  
Roberts WG, 1997, CANCER RES, V57, P765